Application of cost-effectiveness analysis to demonstrate the potential value of companion diagnostics in chronic myeloid leukemia.
Pharmacogenomics
; 12(3): 411-21, 2011 Mar.
Article
in En
| MEDLINE
| ID: mdl-21449679
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Protein Kinases
/
Pyrimidines
/
Thiazoles
/
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
/
Biomarkers, Tumor
/
Microarray Analysis
Type of study:
Diagnostic_studies
/
Health_economic_evaluation
/
Health_technology_assessment
/
Prognostic_studies
Limits:
Humans
Country/Region as subject:
Europa
Language:
En
Journal:
Pharmacogenomics
Journal subject:
FARMACOLOGIA
/
GENETICA MEDICA
Year:
2011
Document type:
Article
Affiliation country:
Country of publication: